The DOI matches its Crossref record; 67 of the 70 references it cites were found in a registry or an index.
The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy In Vitro and In Vivo
Open accessAbstract
Oligomeric forms of amyloid-beta (Abeta) are thought to play a causal role in Alzheimer's disease (AD), and the p75 neurotrophin receptor (p75(NTR)) has been implicated in Abeta-induced neurodegeneration. To further define the functions of p75(NTR) in AD, we examined the interaction of oligomeric Abeta(1-42) with p75(NTR), and the effects of that interaction on neurite integrity in neuron cultures and in a chronic AD mouse model. Atomic force microscopy was used to ascertain the aggregated state of Abeta, and fluorescence resonance energy transfer analysis revealed that Abeta oligomers interact with the extracellular domain of p75(NTR). In vitro studies of Abeta-induced death in neuron cultures isolated from wild-type and p75(NTR-/-) mice, in which the p75(NTR) extracellular domain is deleted, showed reduced sensitivity of mutant cells to Abeta-induced cell death. Interestingly, Abeta-induced neuritic dystrophy and activation of c-Jun, a known mediator of Abeta-induced deleterious signaling, were completely prevented in p75(NTR-/-) neuron cultures. Thy1-hAPP(Lond/Swe) x p75(NTR-/-) mice exhibited significantly diminished hippocampal neuritic dystrophy and complete reversal of basal forebrain cholinergic neurite degeneration relative to those expressing wild-type p75(NTR). Abeta levels were not affected, suggesting that removal of p75(NTR) extracellular domain reduced the ability of excess Abeta to promote neuritic degeneration. These findings indicate that although p75(NTR) likely does not mediate all Abeta effects, it does play a significant role in enabling Abeta-induced neurodegeneration in vitro and in vivo, establishing p75(NTR) as an important therapeutic target for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other putative receptors/co-receptors involved in neuronal binding of Aβ oligomers include the p75 neurotrophin receptor (p75NTR) (Knowles et al., 2009), the receptor for advanced glycation end products (RAGE) (Sturchler et al., 2008), nicotinic acetylcholine receptors (Magdesian et al., 2005) and Frizzled (Magdesian et al., 2008).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Knowles et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015
Sortilin is essential for proNGF-induced neuronal cell death
Nykjaer, A., Lee, R., Teng, K. K., Jansen, P., Madsen, P., Nielsen, M. S., Jacobsen, C., Kliemannel, M., Schwarz, E., Willnow, T. E., et al. (2004) · Nature · doi:10.1038/nature02319 · Cited by 962
Lee, K., Li, E., Huber, L. J., Landis, S. C., Sharpe, A. H., Chao, M. V., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90286-l · Cited by 949
Kayed, R., Sokolov, Y., Edmonds, B. W., McIntire, T. M., Milton, S. C. F., Hall, J. E., & Glabe, C. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400260200 · Cited by 913
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex
Mi, S., Lee, X., Shao, Z., Thill, G., Ji, B., Relton, J. K., Levesque, M., Allaire, N., Perrin, S., Sands, B., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1188 · Cited by 827
p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp
Wang, K., Kim, J. A., Sivasankaran, R., Segal, R. A., & He, Z. (2002) · Nature · doi:10.1038/nature01176 · Cited by 824
Dechant, G., & Barde, Y. (2002) · Nature Neuroscience · doi:10.1038/nn1102-1131 · Cited by 606
Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches
Tsai, J., Grutzendler, J., Duff, K., & Gan, W.-B. (2004) · Nature Neuroscience · doi:10.1038/nn1335 · Cited by 561
MORISHIMA, Y., Gotoh, Y., Zieg, J., Barrett, T., Takano, H., Flavell, R. A., Davis, R. J., Shirasaki, Y., & Greenberg, M. E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07551.2001 · Cited by 486
Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04125.2001 · Cited by 462
Yaar, M., Zhai, S., Pilch, P. F., Doyle, S. M., Eisenhauer, P. B., Fine, R. E., & Gilchrest, B. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119772 · Cited by 331
Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
Cras, P. P., Kawai, M., Lowery, D. E., Gonzalez‐DeWhitt, P. A., Greenberg, B., & Perry, G. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7552 · Cited by 314
p75NTR Is Positively Promiscuous
Barker, P. A. (2004) · Neuron · doi:10.1016/j.neuron.2004.04.001 · Cited by 314
A decade of modeling Alzheimer's disease in transgenic mice
MCGOWAN, E., ERIKSEN, J., & HUTTON, M. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.03.007 · Cited by 287
Vogel, S. S., Thaler, C., & Koushik, S. V. (2006) · Science s STKE · doi:10.1126/stke.3312006re2 · Cited by 253
Knowles, R. B., Wyart, C., Buldyrev, S. V., Cruz, L., Urbanc, B., Hasselmo, M. E., Stanley, H. E., & Hyman, B. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5274 · Cited by 241
β-Amyloid1–42Induces Neuronal Death through the p75 Neurotrophin Receptor
Sotthibundhu, A., Sykes, A. M., Fox, B., Underwood, C. K., Thangnipon, W., & Coulson, E. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0350-08.2008 · Cited by 238
Rockenstein, E. M., Mallory, M. E., Mante, M., Sisk, A., & Masliaha, E. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1247 · Cited by 221
Yeo, T. T. S., Chua-Couzens, J., Butcher, L. L., Bredesen, D. E., Cooper, J. D., Valletta, J. S., Mobley, W. C., & Longo, F. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07594.1997 · Cited by 206
Self-citationWong, T. P., Debeir, T., Duff, K., & Cuello, A. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02706.1999 · Cited by 196
Release of the self-quenching of fluorescence near silver metallic surfaces
Lakowicz, J. R., Malicka, J. B., D’Auria, S., & Gryczyński, I. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00351-8 · Cited by 195
Brendza, R. P., Bacskai, B. J., Cirrito, J. R., Simmons, K. A., Skoch, J. M., Klunk, W. E., Mathis, C. A., Bales, K. R., Paul, S. M., Hyman, B. T., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23269 · Cited by 190
Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease.
Mufson, E. J., & Kordower, J. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.569 · Cited by 188
Jana, A., & Pahan, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404635200 · Cited by 186
Heredia, L., Helguera, P. R., de Olmos, S., Kedikian, G., Vigo, F. S., LaFerla, F. M., Staufenbiel, M., de Olmos, J. S., Busciglio, J. A., Cáceres, A., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5567-05.2006 · Cited by 184
Ferreira, A., Lu, Q., Orecchio, L., & Kosik, K. S. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1997.0615 · Cited by 178
Perini, G., Bianca, V. D., Politi, V., Valle, G. D., Prà, I. D., Rossi, F., & Armato, U. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011797 · Cited by 155
Grace, E. A., Rabiner, C. A., & Busciglio, J. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00241-5 · Cited by 153
Bozyczko‐Coyne, D., O’Kane, T. M., Wu, Z.-L., Dobrzański, P., Murthy, S., Vaught, J. L., & Scott, R. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00294.x · Cited by 151
Amyloid-β Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations
Lombardo, J. A., Stern, E. A., McLellan, M. E., Kajdasz, S. T., Hickey, G. A., Bacskai, B. J., & Hyman, B. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10879.2003 · Cited by 149
Yaar, M., Zhai, S., Fine, R. E., Eisenhauer, P. B., Arble, B. L., Stewart, K. B., & Gilchrest, B. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110929200 · Cited by 148
Maloney, M. T., Minamide, L. S., Kinley, A. W., Boyle, J. A., & Bamburg, J. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3711-05.2005 · Cited by 140
Neuroglobin attenuates β-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo
Khan, A. A., Mao, X. O., Banwait, S., Jin, K., & Greenberg, D. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706167104 · Cited by 135
Yang, T., Knowles, J. K., Lu, Q., Zhang, H., Arancio, O., Moore, L. A., Chang, T., Wang, Q., Andreasson, K. I., Rajadas, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003604 · Cited by 134
Self-citationTraffic at the intersection of neurotrophic factor signaling and neurodegeneration
Salehi, A., Delcroix, J.-D., & Mobley, W. C. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00038-3 · Cited by 131
Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.
Rabizadeh, S., Bitler, C. M., Butcher, L. L., & Bredesen, D. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10703 · Cited by 120
Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease
Verdier, Y., & Penke, B. (2004) · Current Protein and Peptide Science · doi:10.2174/1389203043486937 · Cited by 118
Huber, L. J., & Chao, M. V. (1995) · Developmental Biology · doi:10.1006/dbio.1995.1019 · Cited by 117
On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer’s Disease
Capsoni, S., & Cattaneo, A. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9112-2 · Cited by 110
Cholinergic neuropathology in a mouse model of Alzheimer's disease
German, D. C., Yazdani, U., Speciale, S. G., Pasbakhsh, P., Games, D., & Liang, C. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10737 · Cited by 101
Does the p75 neurotrophin receptor mediate Aβ‐induced toxicity in Alzheimer's disease?
Coulson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03905.x · Cited by 99
Hu, X.-Y., Zhang, H.-Y., Qin, S., Xu, H.-W., Swaab, D., & Zhou, J.-N. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8018 · Cited by 98
Whitby, R. J., Dixon, S., Maloney, P., Delerive, P., Goodwin, B. J., Parks, D. J., & Willson, T. M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060990k · Cited by 92
Longo, F. M., Yang, T., Knowles, J. K., Xie, Y., Moore, L. J., & Massa, S. M. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018316 · Cited by 92
Self-citationNeuroprotective strategies in Alzheimer’s disease
Longo, F. M., & Massa, S. M. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.117 · Cited by 83
Self-citationEnlarged cholinergic forebrain neurons and improved spatial learning in p75 knockout mice
Greferath, U., Bennie, A., Kourakis, A., Bartlett, P. F., Murphy, M., & Barrett, G. L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00976.x · Cited by 80
c‐Jun phosphorylation in Alzheimer disease
Thakur, A., Wang, X., Siedlak, S. L., Perry, G. L., Smith, M. A., & Zhu, X. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21298 · Cited by 80
Amendola, J., & Durand, J. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21818 · Cited by 77
Fogarty, M. P., Downer, E. J., & Campbell, V. A. (2003) · Biochemical Journal · doi:10.1042/bj20021660 · Cited by 66
Hashimoto, Y., Kaneko, Y., Tsukamoto, E., Frankowski, H., Kouyama, K., Kita, Y. A., Niikura, T., Aiso, S., Bredesen, D. E., Matsuoka, M., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02513.x · Cited by 63
Smith, M. I., & Deshmukh, M. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402089 · Cited by 63
Eichler, M. E., Dubinsky, J. M., & Rich, K. M. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09305.x · Cited by 47
Small Molecule Modulation of p75 Neurotrophin Receptor Functions
Longo, F. M., Longo, F., Massa, S. M., & Massa, S. M. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708783885093 · Cited by 39
Self-citationSusen, K., & Blöchl, A. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0671-3 · Cited by 38
Oxidant treatment causes a dose-dependent phenotype of apoptosis in cultured motoneurons
Kaal, E. C. A., Veldman, H., Sodaar, P., Joosten, E. A. J., & Bär, P. R. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981215)54:6 · Cited by 37
A cyclic peptide that binds p75NTR protects neurones from beta amyloid (1–40)‐induced cell death
Yaar, M., Zhai, S., Panova, I. P., Fine, R. E., Eisenhauer, P. B., Blusztajn, J. K., López-Coviella, I., & Gilchrest, B. A. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00844.x · Cited by 37
Noda-Saita, K., Terai, K., Iwai, A., Tsukamoto, M., Shitaka, Y., Kawabata, S., Okada, M., & Yamaguchi, T. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0907-2 · Cited by 30
Neurotrophin-based strategies for neuroprotection
Longo, F. M., & Massa, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6s606 · Cited by 29
Self-citationMolecular studies of pH-dependent ligand interactions with the low-density lipoprotein receptor
Yamamoto, T., Chen, H.-C., Guigard, E., Kay, C. M., & Ryan, R. O. (2008) · Biochemistry · doi:10.1021/bi801117t · Cited by 23
Research works printed but not linked: 1
- 10.1172/JCI200523269 · DOI · Paper page
Cited by
Sorted by citations
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442
Chen, X., & Mobley, W. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00659 · Cited by 302
Luo, J., Elwood, F., Britschgi, M., Villeda, S., Zhang, H., Ding, Z., Zhu, L., Alabsi, H., Getachew, R., Narasimhan, R., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20120412 · Cited by 262
Self-citationIbáñez, C. F., & Simi, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.03.007 · Cited by 238
Metadata
- Authors
- Knowles, J. K., Rajadas, J., Nguyen, T.-V. V., Yang, T., LeMieux, M. C., Vander Griend, L., Ishikawa, C., Massa, S. M., Wyss-Coray, T., & Longo, F. M.
- Affiliations
- Stanford University (US)
- University of North Carolina at Chapel Hill (US)
- VA Palo Alto Health Care System (US)
- San Francisco VA Medical Center (US)
- Corresponding author
- Longo, Frank M.
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-08-26
- Volume
- 29
- Issue
- 34
- Pages
- 10627-10637
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2771439
- OpenAlex
- W2090434536
- Cited by
- 184
- References
- 70
- Citations by year
- 2026: 10 · 2025: 6 · 2024: 6 · 2023: 4 · 2022: 9 · 2021: 14 · 2020: 11 · 2019: 11 · 2018: 4 · 2017: 10 · 2016: 17 · 2015: 14 · 2014: 17 · 2013: 15 · 2012: 12
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- U.S. Public Health Service (F30 NA051971)
- National Institute of Neurological Disorders and Stroke (F30NS051971)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- p75 neurotrophin receptor, amyloid-beta 42, Alzheimer's disease, neuritic dystrophy, amyloid-beta oligomers, c-Jun activation, cholinergic neurons, hippocampus, APP transgenic mice, therapeutic target
- MeSH terms
- Acetylcholinesterase, Alzheimer Disease, Analysis of Variance, Animals, Cell Survival, Cells, Cultured, Disease Models, Animal, Embryo, Mammalian, Enzyme-Linked Immunosorbent Assay, Exons, Hippocampus, Humans, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Nerve Degeneration, Neurons, Peptide Fragments, Spectrophotometry, Atomic, Amyloid beta-Peptides, Neurites, Prosencephalon, Amyloid beta-Protein Precursor, Receptor, Nerve Growth Factor, Fluorescence Resonance Energy Transfer, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review